Literature DB >> 19165622

Frequency and distribution of late gadolinium enhancement in magnetic resonance imaging of patients with apical hypertrophic cardiomyopathy and patients with asymmetrical hypertrophic cardiomyopathy: a comparative study.

Masao Yamada1, Kunihiko Teraoka, Masafumi Kawade, Masaharu Hirano, Akira Yamashina.   

Abstract

Our aim was to compare the frequency and distribution of late gadolinium enhancement (LGE) on contrast MRI between hypertrophic cardiomyopathy (HCM) patients with apical hypertrophic cardiomyopathy (APH) and those with asymmetrical septal hypertrophy (ASH). We studied 66 patients with HCM (50 men and 16 women; average age: 58.8 +/- 29.8 years) who had undergone MRI. All the MRI examinations were performed using a 1.5 T system. LGE images were acquired using the inversion recovery segmented spoiled-gradient echo and phase-sensitive inversion recovery methods. We evaluated 17 segments of the left ventricle as defined by the American Heart Association criteria for LGE determination. LGE was detected at the junction of the right ventricle and the interventricular septum in 25 (73.5%) of the 34 HCM patients with ASH and in the apex of the heart in 13 (40.6%) of the 32 patients with APH. LGE-positive areas were more widely distributed in the case of the ASH group than in the case of the APH group. The distribution of LGE was clearly different between the two groups (Fisher's exact probability test, P = 0.0068). The number of LGE-positive cases and LGE-positive segments were significantly higher in the ASH group than in the APH group and there was a significant difference in the distribution of the LGE-positive areas between the two groups. LGE was mainly detected in the hypertrophied areas of the myocardium.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19165622     DOI: 10.1007/s10554-008-9406-1

Source DB:  PubMed          Journal:  Int J Cardiovasc Imaging        ISSN: 1569-5794            Impact factor:   2.357


  19 in total

Review 1.  Cardiomyopathy: The diagnosis of hypertrophic cardiomyopathy.

Authors:  E D Wigle
Journal:  Heart       Date:  2001-12       Impact factor: 5.994

Review 2.  Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association.

Authors:  Manuel D Cerqueira; Neil J Weissman; Vasken Dilsizian; Alice K Jacobs; Sanjiv Kaul; Warren K Laskey; Dudley J Pennell; John A Rumberger; Thomas Ryan; Mario S Verani
Journal:  Circulation       Date:  2002-01-29       Impact factor: 29.690

3.  Apical hypertrophic cardiomyopathy with aneurysmal degeneration of the apex.

Authors:  Akira Sato; Tsuyoshi Shiga; Hirotaka Kawarai; Naoki Matsuda; Fumiko Kimura; Fumikazu Sakai; Hiroshi Kasanuki
Journal:  Heart Vessels       Date:  2003-03       Impact factor: 2.037

4.  Delayed contrast enhancement of MRI in hypertrophic cardiomyopathy.

Authors:  Kunihiko Teraoka; Masaharu Hirano; Hiroyuki Ookubo; Kazuyoshi Sasaki; Hiroaki Katsuyama; Masayuki Amino; Yimihiko Abe; Akira Yamashina
Journal:  Magn Reson Imaging       Date:  2004-02       Impact factor: 2.546

5.  Images in cardiovascular medicine. Hypertrophic cardiomyopathy with apical aneurysm.

Authors:  Andrey G Zenovich; John R Lesser; Susan A Casey; Barry J Maron
Journal:  Circulation       Date:  2004-10-19       Impact factor: 29.690

Review 6.  ACCF/AHA clinical competence statement on cardiac imaging with computed tomography and magnetic resonance: a report of the American College of Cardiology Foundation/American Heart Association/American College of Physicians Task Force on Clinical Competence and Training.

Authors:  Matthew J Budoff; Mylan C Cohen; Mario J Garcia; John McB Hodgson; W Gregory Hundley; Joao A C Lima; Warren J Manning; Gerald M Pohost; Paolo M Raggi; George P Rodgers; John A Rumberger; Allen J Taylor; Mark A Creager; John W Hirshfeld; Beverly H Lorell; Geno Merli; George P Rodgers; Cynthia M Tracy; Howard H Weitz
Journal:  J Am Coll Cardiol       Date:  2005-07-19       Impact factor: 24.094

7.  Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function.

Authors:  R J Kim; D S Fieno; T B Parrish; K Harris; E L Chen; O Simonetti; J Bundy; J P Finn; F J Klocke; R M Judd
Journal:  Circulation       Date:  1999-11-09       Impact factor: 29.690

8.  The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy.

Authors:  James C C Moon; Emma Reed; Mary N Sheppard; Andrew G Elkington; Siew Yen Ho; Margaret Burke; Mario Petrou; Dudley J Pennell
Journal:  J Am Coll Cardiol       Date:  2004-06-16       Impact factor: 24.094

9.  Detection of apical hypertrophic cardiomyopathy by cardiovascular magnetic resonance in patients with non-diagnostic echocardiography.

Authors:  J C C Moon; N G Fisher; W J McKenna; D J Pennell
Journal:  Heart       Date:  2004-06       Impact factor: 5.994

10.  Relation of electrocardiographic abnormalities and patterns of left ventricular hypertrophy identified by 2-dimensional echocardiography in patients with hypertrophic cardiomyopathy.

Authors:  B J Maron; J K Wolfson; E Ciró; P Spirito
Journal:  Am J Cardiol       Date:  1983-01-01       Impact factor: 2.778

View more
  10 in total

Review 1.  Apical variant hypertrophic cardiomyopathy "multimodality imaging evaluation".

Authors:  Gary Huang; Shaimaa A Fadl; Stan Sukhotski; Manuela Matesan
Journal:  Int J Cardiovasc Imaging       Date:  2019-12-18       Impact factor: 2.357

2.  Association of ST elevation with apical aneurysm in hypertrophic cardiomyopathy.

Authors:  Ozcan Ozeke; Cagatay Ertan; Gokhan Keskin; Bulent Deveci; Serkan Cay; Fırat Ozcan; Serkan Topaloglu; Dursun Aras; Ahmet Duran Demir; Sinan Aydogdu
Journal:  Indian Heart J       Date:  2015-08-08

Review 3.  Multimodality imaging in apical hypertrophic cardiomyopathy.

Authors:  Rosario Parisi; Francesca Mirabella; Gioel Gabrio Secco; Rossella Fattori
Journal:  World J Cardiol       Date:  2014-09-26

4.  Cardiac MRI evaluation of hypertrophic cardiomyopathy: left ventricular outflow tract/aortic valve diameter ratio predicts severity of LVOT obstruction.

Authors:  Jens Vogel-Claussen; Miguel Santaularia Tomas; Amit Newatia; Danielle Boyce; Aurelio Pinheiro; Roselle Abraham; Theodore Abraham; David A Bluemke
Journal:  J Magn Reson Imaging       Date:  2012-05-01       Impact factor: 4.813

5.  ASCI 2010 appropriateness criteria for cardiac magnetic resonance imaging: a report of the Asian Society of Cardiovascular Imaging cardiac computed tomography and cardiac magnetic resonance imaging guideline working group.

Authors:  Kakuya Kitagawa; Byoung Wook Choi; Carmen Chan; Masahiro Jinzaki; I-Chen Tsai; Hwan Seok Yong; Wei Yu
Journal:  Int J Cardiovasc Imaging       Date:  2010-08-24       Impact factor: 2.357

6.  Coexistence of apical hypertrophic cardiomyopathy and endomyocardial fibrosis with calcification: diagnosis using multimodality imaging.

Authors:  Lakshmi Muthukumar; M Fuad Jan; Joseph Whitnah; A Jamil Tajik
Journal:  ESC Heart Fail       Date:  2016-07-28

7.  Apical Hypertrophic Cardiomyopathy: The Variant Less Known.

Authors:  Rebecca K Hughes; Kristopher D Knott; James Malcolmson; João B Augusto; Saidi A Mohiddin; Peter Kellman; James C Moon; Gabriella Captur
Journal:  J Am Heart Assoc       Date:  2020-02-28       Impact factor: 5.501

Review 8.  Anatomical-MRI Correlations in Adults and Children with Hypertrophic Cardiomyopathy.

Authors:  Radu Ovidiu Rosu; Ana Lupsor; Alexandru Necula; Gabriel Cismaru; Simona Sorana Cainap; Daniela Iacob; Cecilia Lazea; Andrei Cismaru; Alina Gabriela Negru; Dana Pop; Gabriel Gusetu
Journal:  Diagnostics (Basel)       Date:  2022-02-14

9.  Myocardial scarring on cardiovascular magnetic resonance in asymptomatic or minimally symptomatic patients with "pure" apical hypertrophic cardiomyopathy.

Authors:  Kyung-Hee Kim; Hyung-Kwan Kim; In-Chang Hwang; Seung-Pyo Lee; Eun-Ah Park; Whal Lee; Yong-Jin Kim; Jae-Hyung Park; Dae-Won Sohn
Journal:  J Cardiovasc Magn Reson       Date:  2012-07-28       Impact factor: 5.364

10.  Is the Increased Septal Perfusion the Signal of Asymmetrical Septal Hypertrophy?

Authors:  Semra Ozdemir; Yusuf Ziya Tan; Emine Gazi
Journal:  World J Nucl Med       Date:  2016-09
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.